| Current Price | $5.98 | Mkt Cap | $512.7M |
|---|---|---|---|
| Open | $5.80 | P/E Ratio | 0.00 |
| Prev. Close | $5.98 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.70 - $6.00 | Volume | 3,261,022 |
| 52-Wk Range | $5.68 - $85.37 | Avg. Daily Vol. | 6,776,795 |
A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases.
| Current Price | $5.98 | Mkt Cap | $512.7M |
|---|---|---|---|
| Open | $5.80 | P/E Ratio | 0.00 |
| Prev. Close | $5.98 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.70 - $6.00 | Volume | 3,261,022 |
| 52-Wk Range | $5.68 - $85.37 | Avg. Daily Vol. | 6,776,795 |
The best Bull and Bear pitches based on recency and number of recommendations.
This company was opportunistic in getting orders and cash from Operation Warp Speed. Management is clearly prepping for growth but I will need to see syringes of vaccine with their name on it before I believe they can bring a drug to market.
Read the most recent pitches from players about NVAX.
Recs
almodovar
(< 20)
Submitted: 11/28/2021 5:34:33 PM :
Start Price:
$228.76
NASDAQ:NVAX Score:
-82.22
good
Recs
jaltman
(71.68)
Submitted: 11/22/2021 2:36:46 PM :
Start Price:
$164.93
NASDAQ:NVAX Score:
-80.93
Covid vaccination play. While I am the most bullish on BNTX, I expect all players in the mRNA Covid vaccine sector (particularly those with vaccines are their primary income source) to outperform the market over the next 1-5 years - and possibly beyond that.
Recs
Roger8838
(< 20)
Submitted: 10/24/2021 6:59:47 AM :
Start Price:
$138.46
NASDAQ:NVAX Score:
-82.34
WHO and FDA approval will cause this to stock to be revalued upwards.
Find the members with the highest scoring picks in NVAX.
MelonsMangos (79.49) Score: +8,573.54
The Score Leader is the player with the highest score across all their picks in NVAX.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| qqqaaazzz | < 20 | 8/1/2017 |
|
5Y | $1.06 | +464.15% | +59.09% | +405.06 | 0 Comment | |
| stockcaps360 | < 20 | 8/1/2017 |
|
5Y | $1.06 | +464.15% | +59.09% | +405.06 | 0 Comment | |
| TMFGBudwell | < 20 | 1/2/2018 |
|
1Y | $1.28 | +367.19% | +46.75% | +320.44 | 1 Comment | |
| bestiashow | 40.01 | 8/13/2018 |
|
5Y | $1.42 | +321.13% | +38.88% | +282.24 | 0 Comment | |
| rjallan | < 20 | 9/8/2009 |
|
3M | $5.74 | +4.18% | +284.01% | +279.83 | 0 Comment | |
| rhinomaj | < 20 | 7/29/2009 |
|
3M | $4.75 | +25.89% | +305.06% | +279.17 | 3 Comments | |
| ReadEmAnWeep | 69.45 | 8/11/2009 |
|
5Y | $5.09 | +17.49% | +293.51% | +276.02 | 0 Comment | |
| AGCAPS | < 20 |
|
|
5Y | $3.11 | +92.28% | +368.14% | +275.86 | 0 Comment | |
| marksaal | 40.93 | 4/28/2009 |
|
1Y | $3.11 | +92.28% | +368.14% | +275.86 | 1 Comment | |
| Zippidy2 | 88.38 | 8/6/2009 |
|
5Y | $4.91 | +21.79% | +296.19% | +274.39 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
